孕20周与28周母血清可溶性fms样酪氨酸激酶-1及胎盘生长因子水平与自发性早产风险
在英国剑桥妊娠结局预测研究的前瞻性队列中,3763例未选择初产妇于孕20周和28周检测血清可溶性fms样酪氨酸激酶-1(sFlt-1)与胎盘生长因子(PlGF)。孕20周较高sFlt-1及sFlt-1:PlGF比值与自发性早产风险降低相关;20至28周sFlt-1及比值升高速率与风险正相关,PlGF升高速率与风险负相关;比值升高最快十分位合并股骨长度增长最慢十分位者风险约9倍。
要点
- 孕20周较高sFlt-1及sFlt-1:PlGF比值与自发性早产风险降低相关。
- 20至28周sFlt-1及sFlt-1:PlGF比值升高速率与自发性早产正相关。
- 比值升高最快十分位合并股骨长度增长最慢十分位者风险约9倍。
核心结论
- sFlt-1与PlGF水平变化提示胎盘功能障碍,与自发性早产风险强相关,尤其合并胎儿股骨长度增长较慢时。
研究设计与样本
- 前瞻性队列分析,纳入英国剑桥妊娠结局预测研究中未选择的初产妇,共3763例参与分析。
- 于孕20周和28周测量母血清sFlt-1、PlGF及sFlt-1:PlGF比值,采用Cox回归和竞争风险回归评估自发性早产风险。
主要发现
- 3763例中95例(2.5%)发生自发性早产,54例(1.4%)发生医学指征早产。
- 孕20周时,sFlt-1每升高1个标准差的自发性早产调整风险比为0.75(95%CI 0.61-0.92;P=.006),sFlt-1:PlGF比值每升高1个标准差的调整风险比为0.71(95%CI 0.59-0.87;P=.0009)。
- 孕28周时,sFlt-1或PlGF与自发性早产风险无关联,但sFlt-1:PlGF比值呈U形关系。
- 20至28周sFlt-1升高速率与自发性早产正相关(调整风险比1.36,95%CI 1.13-1.63;P=.001),sFlt-1:PlGF比值升高速率正相关(1.50,95%CI 1.30-1.73;P<.0001),PlGF升高速率负相关(0.71,95%CI 0.61-0.82;P<.0001)。
- sFlt-1:PlGF比值升高最快十分位且股骨长度增长最慢十分位者,自发性早产风险约9倍(9.27,95%CI 4.21-20.37;P<.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Spontaneous preterm birth is the endpoint of multiple different pathophysiological pathways. Fetal growth restriction, assessed by serial ultrasonic fetal biometry, has been shown to predict both preterm and early-term spontaneous labor. The soluble fms-like tyrosine kinase-1 to placental growth factor ratio is predictive of early-term spontaneous labor, but its association with spontaneous preterm birth is unclear. OBJECTIVE: This study aimed to determine whether maternal serum levels of soluble fms-like tyrosine kinase-1, placental growth factor, and the soluble fms-like tyrosine kinase-1: placental growth factor ratio at 20 and 28 weeks' gestation, and the rate of change in these biomarkers between 20 and 28 weeks were predictive of risk of spontaneous preterm birth. STUDY DESIGN: The biomarkers were measured in maternal serum at 20- and 28-weeks' gestation in women recruited to a prospective cohort of unselected nulliparous women as part of the Pregnancy Outcome Prediction study in Cambridge, United Kingdom. The risk of spontaneous preterm birth was assessed using Cox regression and competing-risks regression. Associations from Cox regression were quantified by the adjusted hazard ratio for a 1 standard deviation higher level of a given biomarker or a 1 standard deviation increase in the marker between 20 and 28 weeks' gestation. A previously identified risk factor, slow femur length growth, was used as an additional predictor of spontaneous preterm birth for the purpose of risk stratification. RESULTS: Of the 3763 participants in the analysis, 95 (2.5%) had spontaneous preterm birth and 54 (1.4%) had medically indicated preterm birth. At 20 weeks' gestation, higher levels of soluble fms-like tyrosine kinase-1 and the soluble fms-like tyrosine kinase-1:placental growth factor ratio were associated with reduced risk of spontaneous preterm birth (adjusted hazard ratio [95% confidence interval], 0.75 [0.61-0.92]; P=.006 and 0.71 [0.59-0.87]; P=.0009, respectively). At 28 weeks' gestation, there was no association between either soluble fms-like tyrosine kinase-1 or placental growth factor and the risk of spontaneous preterm birth, but there was a U-shaped relation with the soluble fms-like tyrosine kinase-1:placental growth factor ratio. However, when the biomarkers were quantified as the rate of increase between 20 and 28 weeks' gestation, there were strong positive associations between spontaneous preterm birth and rate of increase in soluble fms-like tyrosine kinase-1 (1.36 [1.13-1.63]; P=.001) and the soluble fms-like tyrosine kinase-1:placental growth factor ratio (1.50 [1.30-1.73]; P<.0001), and a strong negative association with the rate of increase in placental growth factor (0.71 [0.61-0.82]; P<.0001). Women who were in the highest decile of increase in the soluble fms-like tyrosine kinase-1:placental growth factor ratio and the lowest decile of femur length growth between 20 and 28 weeks' gestation had approximately 9-fold risk of spontaneous preterm birth (9.27 [4.21-20.37]; P<.0001). Competing-risks regression yielded similar results. CONCLUSION: Changing levels of soluble fms-like tyrosine kinase-1 and placental growth factor are indicative of placental dysfunction and are strongly associated with the risk of spontaneous preterm birth, especially when combined with slower fetal femur length growth.
引用
- Sovio U, Gaccioli F, Cook E, et al. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth. Am J Obstet Gynecol. 2023. PMID: 36758709. doi:10.1016/j.ajog.2023.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。